title: [Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?].
abstract: Atrial fibrillation following cardiac surgery remains as a most common complication. Tachycardia with atrial fibrillation just after the operation could lead to cardiac deterioration. Although we have to control tachycardia, we often have great difficulties in managing these arrhythmias. Many reports have showed landiolol, ultra short-acting beta1 blocker, and amiodarone were effective against postoperative atrial fibrillation. However there has been no report on comparison between these 2 drugs. As excessively sympathetic activity might cause atrial fibrillation, landiolol was introduced into our therapy concomitant with the sedative. Our investigation confirmed that both landiolol and amiodarone were effective in preventing atrial fibrillation, and that the timing of transition from intravenous administration to oral intake was acceptable. When landiolol was administered, enough attention should be paid to the patients whose left ventricular function was low. The patients in whom atrial fibrillation occurred under landiolol therapy showed tendency of lower heart rate in comparison with the patients under amiodarone therapy.
authors.affiliation: Department of Surgery, Cardiovascular Center, Kitano Hospital, Osaka, Japan.
authors.forename: Kyokun
authors.initials: K
authors.lastname: Uehara
authors.forename: Koji
authors.initials: K
authors.lastname: Ueyama
authors.forename: Hidehiro
authors.initials: H
authors.lastname: Ito
authors.forename: Terunobu
authors.initials: T
authors.lastname: Fukuda
authors.forename: Kenichi
authors.initials: K
authors.lastname: Sasaki
authors.forename: Tomomi
authors.initials: T
authors.lastname: Abe
authors.forename: Eisaku
authors.initials: E
authors.lastname: Nakane
authors.forename: Shoichi
authors.initials: S
authors.lastname: Miyamoto
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Haruna
authors.forename: Moriaki
authors.initials: M
authors.lastname: Inoko
authors.forename: Ryuji
authors.initials: R
authors.lastname: Nohara
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D011183:Postoperative Complications; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D009025:Morpholines; C077049:landiolol; D014508:Urea; D000638:Amiodarone